Hyperactive mariner transposons are created by mutations that disrupt allosterism and increase the rate of transposon end synapsis by Liu, Danxu & Chalmers, Ronald
Hyperactive mariner transposons are created by
mutations that disrupt allosterism and increase
the rate of transposon end synapsis
Danxu Liu and Ronald Chalmers*
School of Life Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham NG7 2UH, UK
Received October 1, 2013; Revised November 3, 2013; Accepted November 5, 2013
ABSTRACT
New applications for transposons in vertebrate
genetics have spurred efforts to develop hyper-
active variants. Typically, a genetic screen is used
to identify several hyperactive point mutations,
which are then incorporated in a single transposase
gene. However, the mechanisms responsible for the
increased activity are unknown. Here we show that
several point mutations in the mariner transposase
increase their activities by disrupting the allostery
that normally serves to downregulate transposition
by slowing synapsis of the transposon ends. We
focused on the conserved WVPHEL amino acid
motif, which forms part of the mariner transposase
dimer interface. We generated almost all possible
single substitutions of the W, V, E and L residues
and found that the majority are hyperactive.
Biochemical analysis of the mutations revealed
that they disrupt signals that pass between
opposite sides of the developing transpososome
in response to transposon end binding. In addition
to their role in allostery, the signals control the
initiation of catalysis, thereby preventing non-
productive double-strand breaks. Finally, we note
that such breaks may explain the puzzling ‘self-
inflicted wounds’ at the ends of the Mos1 trans-
poson in Drosophila.
INTRODUCTION
For many years, the Tn10 and P element transposons
have been used successfully as genetic tools in
Escherichia coli and Drosophila (1,2). More recently,
Sleeping Beauty and PiggyBac systems have been
developed for cancer gene discovery and transgenic
applications in vertebrates (3–5). By combining several
independently isolated point mutations, the PiggyBac
and Sleeping Beauty transposition rates have been
increased by 17- and 100-fold, respectively (6,7).
For most genes, such as those involved with
housekeeping functions, it is difﬁcult to generate hyperac-
tive variants. This is because biological systems usually
occupy summits on the local ﬁtness landscape. In
contrast, it is relatively easy to isolate hyperactive eukary-
otic transposases. The explanation may be that trans-
posons that have acquired detrimental mutations
continue to be ampliﬁed owing to the active transposase
provided by other copies of the element. Therefore, this
relaxation of natural selection may allow the transposases
sequences to drift off the local ﬁtness summit (8,9).
Furthermore, transposons are probably also subject to
stabilizing selection, which will balance their selﬁsh amp-
liﬁcation against detrimental effects on host ﬁtness. In
principle, any variation that reduces activity can mediate
stabilizing selection. However, modeling suggests that
transposons require active regulation for survival (10).
At the start of a genomic invasion, when the copy
number is low, a high rate of transposition is desirable
to protect the element from genetic drift. Later, as the
copy number increases, a progressively lower rate of trans-
position (per copy) will protect host ﬁtness. Therefore,
Hyperactive variants may arise from the reversal of detri-
mental mutations or the relaxation of autoregulation.
Currently, the most widely used transposon tool is a
hyperactive Tn5. It is an effective in vivo mutagen and
has numerous post-genomic applications such as the
delivery of sequence bar codes and deep-sequencing
primers. Hyperactivity depends on three point mutations,
which inactivate the transposon’s natural autoregulatory
mechanisms (11,12). Although two of the mutations were
selected from random libraries, M56A was informed by
prior knowledge of autoregulation.
Our knowledge of autoregulation in eukaryotic trans-
posons remains sparse. However, recent ﬁndings show
that in the mariner transposon Hsmar1, it arises from a
competition for transposase binding sites at the trans-
poson ends (13). We refer to this as an assembly site
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occlusion (ASO) model. In Hsmar1, the mechanism is
augmented by allosteric interactions between the
transposase subunits: The free transposase probably has
a 2-fold symmetry because this is the lowest energy state
for a homodimer. If so, the DNA binding domains will
have the same afﬁnity for transposon ends. However,
binding of the ﬁrst transposon end reduces the afﬁnity
of the unoccupied site by orders of magnitude (13,14).
We view this as a form of allosterism between the
subunits because the status of one dictates the properties
of the other. The low afﬁnity of the developing
transpososome for the second transposon end reduces
the rate of synapsis and increases the competition for
binding sites, which imposes effective autoregulation at a
low transposase concentration (13).
The crystal structure of the mariner Mos1
transpososome provides a clear view of the dimer interface
in the post-cleavage intermediate. Even though the dimer
interface most likely changes as the reaction progresses,
the structure highlights regions of the protein that may
be determinants of the allosterism. Most of the dimer
interface is contributed by the ‘clamp-loop’ and ‘linker’
regions (15). The linker connects the DNA binding and
catalytic domains and harbors the conserved WVPHEL
motif (Figure 1A and B). The clamp-loop extends from
the catalytic core of one monomer and interacts with the
WVPHEL motif of the other (Figure 1C and D). The most
striking protein–protein contacts are between a pair of
conserved arginine (R) residues, which sandwich the
plane of the aromatic tryptophan (W) side chain
(Figure 1D and E). The clamp-loop also interacts non-
speciﬁcally with the transposon end on the opposite side
of the complex, providing a mechanism whereby binding
might be signaled across the complex.
Alanine-scanning mutagenesis of the WVPHEL motif
in the related Himar1 yielded hyperactive transposases
at four of the six positions (22). In principle, the particular
residues could be present owing to genetic drift or
stabilizing selection. However, the clustering of the muta-
tions in a conserved motif suggests that their role is active,
rather than passive, whereas their location in the heart of
the dimer interface suggests that it may involve the afore-
mentioned allostery. In the present work, we characterized
almost all possible single mutations of the WVPHEL
motif and found that most yield hyperactive transposases.
Consistent with location of the mutations in the heart of
the dimer interface, we also demonstrated that the hyper-
activity arises from the disruption of allostery between the
subunits and the resulting relief from autoregulation.
Although the overall effect of the mutations is to
increase the rate of transposition, the mutations allow
off-pathway reactions that damage the DNA.
MATERIALS AND METHODS
Materials were generally of the best quality available from
commercial suppliers. Hsmar1 transposase was expressed,
puriﬁed and assayed as described in (14,23). Transposase
expression plasmids for puriﬁcation and papillation were
created by cloning the respective transposase genes in
pMAL c2X (New England Biolabs) between the EcoR1
and BamH1 restriction endonuclease sites. pRC880
encodes the wild-type transposase; pRC1230–1235
encode W118V, W118R, V119T, E122R, L123S, L123N;
and pRC1248-1249 encode W118R+E122R and
W118R+L123N transposases, respectively. Plasmids
pRC1251-1259 encode R166A, K182A, R166A/K182A,
W118D/R166A, W118D/K182A, W118D/R166/A/
K182A, Y275A, P267A and L278A transposases, respect-
ively. Further details of methods are given in the ﬁgure
legends. For the papillation assay, expression plasmids
N CHTH HTH WVPHEL D  D  D
DNA binding CatalysisLinker
B *       *             *Mos1     ...WVPHEL...DEKW...HDNA...YSPDL...DY...
Famar1   ...WVPHEL...DEKW...HDNA...YSPDL...DY...
Mboumar9 ...WVPHEL...DEKW...HDNA...YSPDL...DY...
Hsmar1   ...WVPHEL...DEKW...HDNA...YSPDL...DY...
D1      D2            D3
A
Mos1          ...RKKSYVDPGQPATSTAR
Famar1        ...RKRSWGRPGEPAQTTSK
Mboumar9      ...RKKSWLSPGEAGPSTAR
Hsmar1        ...RSAQWLDREEAPKHFPK
R              R/K
E
C D Clamp-
loop
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Figure 1. Structural features of the mariner transposase.
(A) Transposase has an N-terminal DNA binding domain (amino
acids 1–115 approximately) with two helix-turn-helix motifs (HTH).
The catalytic domain (amino acids 125–343) has a triad of conserved
aspartate residues (DDD), which coordinate the catalytic Mg2+ ions.
The domains are connected by a proteolitically sensitive linker region,
which harbors the conserved WVPHEL sequence motif. (B) Hsmar1
transposase is aligned with the sequences of three naturally active
mariner elements (16–19). In addition to the catalytic triad, mariner
has two highly conserved sequence motifs: WVPHEL and YSPDL
(20,21). (C and D) The structural relationships between the conserved
sequence motifs as they appear in the crystal structure of the Mos1
post-cleavage intermediate (15). A long unstructured ‘clamp-loop’ is
found inserted between two strands of the core b sheet. The loop
extends across the dimer interface and contacts the WVPHEL motif
of the opposite subunit. The tryptophan (W) residue is sandwiched
between two arginine residues (R). WVPHEL also contacts the
YSPDL sequence motif, which is connected to the third active site D
residue by a stretch of three residues (A-P-S). Dashed lines indicate
breaks in the drawing scale, which is approximate. Also note that the
residues in the two dimensional cartoon are arranged to give the most
accurate overall picture of the relationships between the structural
elements and that some distortions are inevitable. (E) The region of
Hsmar1 between the conserved basic residues in the clamp-loop is
aligned with the sequences of the three naturally active mariner
elements from part B.
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were transformed into the reporter strain E. coli RC5096
(later in the text). It encodes a transposon with a promoter-
less lacZ and a kanamycin resistance gene inserted at a
transcriptionally silent chromosomal locus in a lac
strain of E. coli. Because the lacZ gene is not expressed,
the strain produces white colonies on X-gal indicator
plates. Transposase is supplied in trans from a plasmid
expression vector. If the transposon integrates into an ex-
pressed gene in the correct reading frame, a lacZ fusion
protein is produced. Expression of lacZ in the descendants
of the original cell is revealed by the outgrowth of blue
papillae on X-gal indicator plates. The assay is further
illustrated in Supplementary Figure S1 and described in
references (24,25). The bacterial mating out assay was
based on (24). We ﬁrst introduced a chloramphenicol re-
sistant derivative of the conjugative plasmid pOX38 into
the papillation reporter strain. Transposition of the lacZ-
kan reporter from the chromosome into the plasmid is
detected by selecting for kanamycin and chloramphenicol
resistant transconjugants after mating with a recipient
strain. E. coli strains were RC5096 [F- fhuA2 (lacZ)r1
glnV44 e14-(McrA-) trp-31 his-1 rpsL104 xyl-7 mtl-2
metB1 (mcrC-mrr)114::IS10 argE::Hsmar1-lacZ’-kanR]
and RC5097 (= RC5096 pOX38::miniTn10-CAT); recipi-
ent strain was RC5094 [F- araD139 (argF-lac)U169
rspL150 relA1 ﬂbB5301 fruA25 deoC1 ptsF25 rpoS359::
Tn10].
HeLa cell assays were as described by (26). The respect-
ive reporter and transposase expression plasmids were
created by replacing the Sleeping Beauty sequences with
Hsmar1 sequences. Transposase expression plasmids for
the HeLa assays were pRC1241–1249, which encode the
wild-type, W118V, W118R, V119T, E122R, L123S,
L123N, W118R/E122R and W118R/L123N.
RESULTS
Most WVPHEL mutations produce hyperactive
transposases
To provide a visual assessment of the rate of Hsmar1
transposition, we established a papillation assay
(illustrated in Supplementary Figure S1). A reporter
transposon containing a promoter-less lacZ gene and a
kanamycin resistance marker was integrated at a tran-
scriptionally silent locus on the chromosome of a lac
E. coli strain. The strain is kanamycin-resistant but
because the lacZ gene is not expressed, it produces
white colonies on X-gal indicator plates. Transposition
yields a lac+ phenotype if the reporter integrates into
an expressed gene in the correct reading frame. On an
indicator plate this is revealed by the outgrowth of blue
papillae on the background of a white colony. In the
presence of the wild-type transposase a typical colony
will develop 20 dark-blue papillae after 3–4 days incu-
bation (Figure 2A).
To explore the phenotypes of mutant proteins, we used
oligonucleotide-directed mutagenesis to randomize the
W118 codon. This yielded a library of plasmids in which
all 64 codons are in principle represented equally at this
position. DNA sequencing conﬁrmed that all four
nucleotides were present at each position
(Supplementary Figure S2). When the library was trans-
formed into the papillation reporter strain, most of the
papillating colonies did so at a higher rate than wild-
type (Figure 2A). There were also a signiﬁcant number
of colonies that did not papillate at all. DNA sequencing
revealed that these clones had stop codons or frame shifts
introduced during construction of the library. Therefore,
it appears that almost all possible substitutions of W118
yield an increase in the rate of transposition.
We generated further libraries of mutations for the
remaining ﬁve codons of the WVPHEL motif. The V, E
and L positions also yielded a high proportion of hyper-
papillating clones (Figure 2A). In contrast, mutagenesis of
the P and H residues yielded mostly hypoactive clones
(Figures 2A and Supplementary Figure S3).
Interacting-residue substitutions are hypoactive
The W118 residue is sandwiched between a pair of
conserved basic residues in the Mos1 clamp-loop region
(Figure 1C–E). Therefore, we wondered if a reciprocal
mutation would confer a hyperactive phenotype. This
was not the case, and the R166A and K182A single and
double substitution proteins were hypoactive in the
papillation assay (Figure 2B).
The WVPHEL motif also interacts with the conserved
YSPDL motif (Figure 1C and D). The most extensive
WT T'ase W118 X V119 XNo T'ase
A
P120 X H121 X E122 X L123 X
R166A K182A R166A/
K182A
R166A/
W118D
K182A/
W118D
R166A/
K182A/
W118D
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B
P276A L278AY274A
C
Figure 2. Bacterial papillation assay and genetic screen. An expression
vector encoding the transposase was transformed into the papillation
reporter strain. Representative ﬁelds of papillating colonies are shown.
The entire plates are also shown in Supplementary Figure S3. (A) Cells
were transformed with individual libraries of mutation for each of the
WVPHEL residues, as indicated. (B and C) Site-speciﬁc mutations were
introduced as indicated. One representative colony is shown.
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contacts are via the P-H residues, which yielded mostly
hypoactive clones in the papillation assay. This suggests
that this interface may be fundamentally important over-
and-above any regulatory functions of the WVPHEL
motif. This seems to be the case because the alanine sub-
stitutions of the Y, P and L residues are all hypoactive in
the papillation assay (Figure 2C).
Saturation mutagenesis of the WVPHEL motif
The randomized-codon libraries for the respective
WVPHEL residues were individually transformed into
E. coli and plated for single colonies. We sequenced
batches of clones until we had obtained at least 16 of the
19 possible substitutions of the W, V, E and L residues. We
assessed the activities of the mutations using a quantitative
‘mating-out’ assay, which measures the rate of transpos-
ition of the reporter from its chromosomal locus into a
conjugative plasmid (Table 1 and Supplementary Table
S1). Of the 17 substitution proteins obtained for the
W118 residue, 15 had activities ranging from wild-type to
30-fold more than wild-type. The phenotypes of the V119
substitution proteins were more variable: nine were
hypoactive and seven were hyperactive. The E122 and
L123 substitutions were similar to those at W118, the
great majority being hyperactive.
To analyze the behavior of the substitutions at the P
and H positions, we selected a few clones from the
papillation plates across the range of activities observed.
The identities of the substitutions were determined by
DNA sequencing and their activity quantiﬁed in the
mating-out assay (Table 1). Only the H121W substitution
protein had an activity as high as wild-type. To search for
more hyperactive clones, we screened another 1000 clones
of the P and H substitution libraries. We sequenced the
16 most active clones but recovered only H121W or
wild-type.
Of the 17 mutations obtained for the W118 residue,
only the D substitution protein yielded a hypoactive
transposase. We hypothesized that it might block the
reaction through an ionic interaction with one of the
ﬂanking arginine residues (Figure 1C and D). We there-
fore tested the W118D substitution protein in combin-
ation with the R166A and K182A single and double
mutants, but none of the combinations rescued the
activity (Figure 2B).
Target site speciﬁcity
Previously, a two-hybrid genetic screen suggested that
the L124S mutation in Mos1 disrupted subunit inter-
actions (27). In addition, the mutation reduced in vitro
transposition >20-fold and altered the ﬁdelity of the
reaction for the TA dinucleotide target site. In
contrast, L123S, the equivalent mutation in Hsmar1,
increased transposition by 50-fold in the bacterial assay
(Table 1). To assess the target dinucleotide speciﬁcity of
the Hsmar1 mutants, we sequenced the junctions of four
or ﬁve independent in vitro insertion events for the
W118V, V119T, E122T and L123S hyperactive
transposases (Supplementary Figure S4). Except for
one of the nine insertions produced by the W118
mutants, all were perfectly canonical and duplicated
the TA dinucleotide target sequence.
Table 1. Transposition frequencies of individual mutants
Mutation W V P H E L
Mutant/W.T. Mutant/W.T. Mutant/W.T. Mutant/W.T. Mutant/W.T. Mutant/W.T.
Small
G 1 0.03 nd 0.08 0.4 20
A 8 3 0.5 nd 3 5
Nucleophilic
S 20 7 nd 0.09 6 50
T 8 7 nd 0.3 8 20
C 8 2 0.4 nd 1 0.7
Hydrophobic
V 10 1 0.6 nd 10 6
L 6 0.1 0.4 nd 4 1
I 4 3 nd nd 2 3
M 10 nd nd nd nd 0.8
P 4 0.02 1 nd 0.2 0.06
Aromatic
F 8 0.2 nd 0.4 2 0.09
Y nd 0.06 nd 0.5 5 nd
W 1 nd nd 1 2 nd
Acidic
D 0.3 nd nd nd 0.08 20
E 2 3 nd nd 1 7
Amide
N nd 0.8 nd nd 0.6 60
Q 8 2 0.01 nd 6 3
Basic
H 10 0.3 nd 1 2 0.1
K 10 0.4 0.04 0.2 7 nd
R 30 0.02 nd nd 30 0.9
Transposition frequencies were measured by the bacterial mating-out assay and are the average of three independent experiments. The transposition
frequency is obtained by dividing the total number of transconjugants containing the transposon by the total number of transconjugants. Mutant/
wild-type transposase (W.T.) ﬁgures are rounded to one signiﬁcant ﬁgure. nd, not determined.
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WVPHEL substitution proteins are hyperactive in HeLa
cells
A selection of the hyperactive substitution proteins was
assessed in a eukaryotic cell culture assay. The assay is
based on the cotransfection of a ‘helper plasmid’ that
expresses transposase and a ‘donor plasmid’ carrying a
transposon with a neomycin marker (illustrated in
Supplementary Figure S5). The rate of transposition is
given by the number of stable transfectants obtained
after drug selection. Typical results for the W118R and
V119T transposases are shown in Figure 3A. Although
these substitutions increased activity 30- and 7-fold in
the mating-out assay, respectively, they increased activity
only 4-fold in HeLa cells. We also tested four other V, E
and L substitutions, but in all cases the extent of the
hyperactivity in HeLa cells was lower than in the bacterial
assay (Supplementary Figure S6). We also tested two
double mutants, W118R+E122R and W118R+L123N,
which were both less active than either of the single
mutants from which they were derived (Supplementary
Figure S6).
WVPHEL substitutions relieve overproduction inhibition
Some eukaryotic DNA transposons are subject to over-
production inhibition (OPI): an increase in transposase
concentration beyond a certain point reduces the rate of
transposition rather than increasing it. We recreated this
effect by titrating the concentration of the wild-type and
V119T helper plasmids in the HeLa assay [Figure 3B: for a
proof of principle control experiment see Figure 5 and
Supplement 1 of reference (13)]. The activity of the wild-
type transposase peaked at 4–16 ng of helper and then
declined. Peak activity for the V119T transposase was
about 3-fold greater, but it was less strongly inhibited at
higher expression levels (Figure 3C). At the highest expres-
sion level, the advantage enjoyed by the V119T protein
had increased from 3-fold to almost 10-fold.
We next used an in vitro assay to assess the sensitivity of
the mutants to the excess transposase responsible for the
OPI phenomenon. The excision steps of the reaction are
illustrated in Figure 4A. Following synapsis, the ﬁrst nick
at one transposon end converts the supercoiled substrate
to the nicked intermediate (14,23). Second strand nicking
is signiﬁcantly slower and produces the linear intermedi-
ate, followed by the complete separation of the transposon
from the backbone. Because we have generated a total of
78 mutant transposases, (Table 1) it would be too time-
consuming to characterize them all to the same extent.
However, we have performed in vitro kinetic analysis
with at least two mutations at each of the hyperactive
W, V, E and L positions (namely, W118R, W118D,
W118V, V119T, V119G, E122T, E122F, L123S and
L123G). Their behaviors were consistent with the more
detailed in vitro analysis presented for selected examples
mentioned later in the text.
We began by titrating the supercoiled substrate over a
range of transposase concentrations (Figure 4B). The
W118V, W118R and V119T mutants continued to excise
the transposon at the highest transposase concentration,
which was sufﬁcient to inhibit the wild-type protein almost
completely (Figure 4B). This conﬁrms the ﬁnding from
Figure 3B and C suggesting that the V119T mutant is
resistant to OPI in the HeLa cell assay, and that this is
likely to be a general property of the mutants.
The OPI model predicts that in vitro reactions with a
relaxed plasmid substrate should be more sensitive to OPI
than with a supercoiled substrate (13). This is because the
absence of supercoiling reduces the rate of synapsis by
lowering the relative concentration of the transposon
ends (14). Slow synapsis, in turn, potentiates OPI by
providing more opportunity for free transposase dimers
to saturate the transposon ends (13). It is worth noting
that slow synapsis is the same mechanism that underlies
the increased OPI due to the allostery mentioned earlier in
the text.
Consistent with the prediction, the reaction with the
wild-type transposase was more sensitive to OPI with
the relaxed plasmid substrate (Supplementary
Figure S7A and D).
This was also true for the W118R and V119T
transposases. However, as before, the mutants were less
sensitive to OPI than to wild-type and the reactions were
faster at all transposase concentrations. This is most easily
seen by comparing Supplementary Figure S7D and F.
Together these results suggest that the resistance to OPI
could in principle be due to faster synapsis with the
mutant proteins. Finally, we also note that under OPI
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Figure 3. WVPHEL mutants are hyperactive in HeLa cells. (A) Cells
were transfected with 500 ng donor and 8 ng helper. After 14 days
growth in G418 media, the cells were ﬁxed, stained with 1% methylene
blue in 70% ethanol and the stable transfectants were counted. Results
with additional mutants are presented in Supplementary Figure S4.
(B) Transfections with 500 ng donor plasmid were titrated with an
increasing amount of wild-type and V119T helper plasmids. Error
bars are the standard error of the mean after three independent experi-
ments. Transposase expression across this range is not toxic (13).
(C) The relative activity of the V119T mutation compared with wild-
type from part B is plotted against the amount of helper plasmid.
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conditions the mutant transposase degrade the DNA to
various extents (e.g. Figure 4B and Supplementary
Figure S7E and F).
Synapsis and initiation of catalysis
Although a supercoiled inverted-repeat substrate allows
all of the chemical steps of the reaction to be observed
in vitro, synapsis of the transposon ends is too fast to
measure accurately. The most stringent conditions for
synapsis are when a plasmid substrate encodes a single
transposon end. The low relative concentration of trans-
poson ends and their greater freedom of motion mean that
synapsis is by far the slowest step and its rate can be
estimated from the appearance of integration products
(14). Reactions with a single-end substrate yield a
complex array of species (illustrated in Supplementary
Figure S8), which are resolved into a background smear
during electrophoresis. However, the canonical intermo-
lecular product is homogeneous in size and runs in a clear
area of the gel. Furthermore, its genesis is unambiguous:
synapsis and cleavage of transposon ends followed by in-
tegration into an unreacted plasmid yields a linear product
three times as large as the substrate (3 in Supplementary
Figure S8).
To determine whether the hyperactive transposases
perform synapsis faster than wild-type, we analyzed the
kinetics of two mutants with the single-end substrate
(Figure 4C and Supplementary Figure S9). The W118V
and V119T transposases both reacted much faster than
wild-type. Because synapsis is the rate limiting step, this
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Figure 4. In vitro analysis of WVPHEL mutants. (A) The excision stage of an in vitro transposition reaction with a supercoiled substrate is
illustrated. Sequential nicking at the transposon ends yields nicked and linear-substrate intermediates. The plasmid backbone is an end product
of the reaction, which provides a direct measure of the efﬁciency. The excised transposon goes on to yield integration products. Transposon ends are
denoted by the open boxes. Products are shown as they appear after deproteination. (B) In vitro transposition reactions with 6.6 nM double-ended
supercoiled-plasmid substrate were titrated with increasing amounts of the indicated transposases. Reactions were deproteinated and analyzed by
agarose (1.1%) gel electrophoresis and stained with ethidium bromide. The efﬁciency of the reaction is given by consumption of the substrate and/or
production of the backbone: for details see references (14,23). Tn indicates the position of the excised transposon. However, this is not visible because
integration is faster than excision. Question mark indicates a non-canonical product, which had not yet been characterized. (C) Kinetic analysis of
transposition with 13.2 nM single-ended substrate and 10 nM of the indicated transposases. Reactions were stopped at indicated times and analyzed
as in part B. Inter-mol. is the intermolecular transposition product illustrated in Supplementary Figure S8. SC’d indicates supercoiled substrate.
Molecular weight markers are as in part B. 1=3kb, 3=9kb. (D) EMSA binding reactions contained 2.5 nM radiolabeled transposon end and
5 nM transposase. Complexes were allowed to form for 5min before addition of a 10-fold molar excess of unlabeled transposon end at time zero. In
this ﬁgure part, some of the lanes have been stretched vertically to bring the respective bands into alignment and correct for the 2 h difference in
loading time. The entirety of the unaltered gels, with additional time points, is provided in Supplementary Figure S10. (E) Kinetic analysis of the
V119T mutant at the indicated transposase concentrations was as in part C. Molecular weight markers are as in part B.
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shows that the hyperactive transposases are more proﬁ-
cient for this step of the reaction.
As a further conﬁrmation of this result, we assayed
assembly of the transpososome using an electrophoretic
mobility shift assay (EMSA) (Figure 4D and
Supplementary Figure S10). Two complexes are detected
in this assay. Single-end complex 2 (SEC2) represents a
transposase dimer bound to a transposon end. Single-
end complex 1 (SEC1) represents a transposase
monomer bound to a transposon end. SEC1 is produced
during electrophoresis by the decay of the paired-ends
complex and/or an immediate precursor [see Figure 3
and Supplement 2 of reference (13) for a full demonstra-
tion and explanation of this phenomenon]. SEC1 can
therefore be used as a proxy for the rate of synapsis.
We performed the EMSA assay by mixing transposase
with linear transposon ends and allowing 5 min for
the complexes to form (Figure 4D). At time 0, we added
a 10-fold molar excess of unlabeled transposon end as a
competitor. Before addition of the competitor, the
mutants had produced much more SEC1 than wild-type.
This suggests that they assemble the transpososome more
quickly and is consistent with the results in Figure 4C.
After addition of the competitor, the labeled trans-
poson end was gradually released as the transposase
redistributed onto the unlabeled competitor. This shows
that the ‘OFF-rates’ for the mutant and wild-type
transposases are approximately the same. This is import-
ant because a higher OFF-rate would reduce OPI (13).
When we assayed the hyperactive mutants (W118V and
V119T) under OPI conditions, intermolecular transpos-
ition was inhibited, as expected (Figure 4E and
Supplementary Figure S9A–C). However, nicking and lin-
earization of the substrate increased when the transposase
concentrationwas increased. This contrasts greatly with the
wild-type transposase in which these activities are almost
completely absent (Supplementary Figure S9A). To char-
acterize the non-canonical nuclease activities of the
mutants, we puriﬁed the linear product and used restriction
endonuclease digestion to show that it arises from double
strand cleavage of the DNA at the transposon end.
When we incubated the mutant transposases with a
plasmid lacking a transposon end, we found that
nicking activity was greatly reduced and the linearization
activity was almost completely absent (Supplementary
Figure S9D–F). Because these non-canonical activities
are largely dependent on the presence of a transposon
end, it seems likely that they are due to the decoupling
of catalysis from synapsis.
DISCUSSION
Kinetic analysis of the hyperactive mutants suggests that
they are less sensitive to OPI because they assemble the
transpososome more quickly. The strongest evidence is
provided by reactions with the single-end plasmid, which
have the most stringent conditions for synapsis and in
which the genesis of the intermolecular product is unam-
biguous (Figure 4C).
The behavior of the mutants is most easily appreciated
in the context of the normal transposition reaction, which
is illustrated on the left side of Figure 5. The ﬁrst step of
the reaction is when a transposase dimer binds to a trans-
poson end. We assume that the free transposase dimer
(blue) must have a 2-fold symmetry because this is the
lowest energy state for a homodimer. This symmetry is
necessarily lost when the dimer binds the ﬁrst transposon
end. The loss of symmetry is associated with an allosteric
change between the subunits that reduces the afﬁnity of
the unbound DNA binding domain for the second trans-
poson end compared to the ﬁrst (13,14). To be consistent
with a neutron diffraction study on this complex (SEC2),
this intermediate is illustrated as an extended structure in
which the catalytic domains are far apart and are held
together by an interaction involving at least one of the
two DNA binding domains (28). After synapsis, which
is by recruitment of a naked transposon end, the
components on either side of the complex are identical.
Presumably the structure must now therefore have a
2-fold symmetry in which the transposon ends are
bound with equal afﬁnity. This would require another
substantial conformational change (bracketed step).
Synapsis culminates in the activation of the complex for
chemical catalysis (stippled green). The present results
suggest that the WVPHEL motif acts as a relay for
Binding &
conformational
change
(Fast)
Conformational
change (Slow)
Excision &
integration
Synapsis
Unconstrained
nicking (Fast)
Mutant fast
synapsis pathway
Wild type slow 
synapsis pathway
Unconstrained cleavage 
Slow
OPI
Fast
Fast
Unconstrained
cleavage (Slow)
Figure 5. A model for the mechanism of the hyperactive mutants. The
transposase DNA binding and catalytic domains are represented as
small and large blobs, respectively. Transposon ends are indicated as
open boxes. We assume that the free transposase dimer (blue) must
have a 2-fold symmetry because this is the lowest energy state for a
homodimer. This symmetry is necessarily lost when the dimer binds the
ﬁrst transposon end and then restored when it binds the second trans-
poson end. Conformational changes are indicated by changing colors.
Green stippled oval represents the activated catalytic domain. Green
hexagon represents the pseudo-activated catalytic domain of the
mutants. Full details of the model are provided in the Discussion
section.
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signals between opposite sides of the transpososome
during assembly. These signals have a dual function in
downregulating transposition and coordinating the
chemical steps of the reaction.
Coordination is important because aberrant events,
such as those that might take place at an unsynapsed
transposon end, are non-productive and potentially
genotoxic. In Tn5 and Mos1, coordination of catalysis is
reﬂected in the trans-architecture of the post-cleavage
intermediates; the transposase subunit bound to one trans-
poson end contributes its active site to the partner end
(15,29). Because the unbound Tn5 transposase is mono-
meric, the trans-architecture is established during
synapsis. In contrast, mariner transposase binds as a
dimer and must therefore have a different mechanism to
suppress single-end activity. Our results suggest that this
comprises of conformational changes, which are
transmitted across the complex in response to trans-
poson-end binding. Interactions between the clamp-loop
and the WVPHEL linker, which represent a second trans-
architectural aspect of the mariner transpososome struc-
ture, act as a conduit for the signals (Figure 1C and D).
In vitro, with optimum transposase concentrations, the
hyperactive WVPHEL mutants react faster than wild-type
(Figure 4C and the panels with 10 and 20 nM transposase
in Supplementary Figure S7). Under OPI conditions, when
the transposon ends are saturated with dimers and there
are few naked ends available for synapsis, the wild-type
reaction is inhibited (e.g. Figure 4B and Supplementary
Figure S7A). Canonical transposition with the mutants is
also inhibited. However, the mutants continue to consume
the substrate rapidly (Figure 4E: but for a clear example
focus on the 1-h time points in Supplementary Figure S7A
and C). If this ‘mutant-OPI-activity’ was taking place
within a normal synapsis, the reaction would progress
with the usual kinetics. However, it does not, and second
strand cleavage is slow, as shown by the accumulation of
the nicked intermediate and its slow conversion to linear
and backbone under OPI conditions. This indicates that
the mutants are more proﬁcient for nicking before
synapsis than wild-type. This conclusion is supported
by the reactions with the single-ended substrate and the
no-end control plasmid (Figure 4E and Supplementary
Figure S9). With the wild-type and mutant transposases
alike, the canonical 3 intermolecular transposition is
absent under OPI conditions (Figure 4E and
Supplementary Figure S9). However, as before, the
hyperactive mutants perform fast nicking and slow linear-
ization by cleavage at unsynapsed transposon ends. This is
illustrated on the right of Figure 5 where the mutants attain
a pseudo-activated state (green decagon). Thus, under
severe OPI conditions the mutants may remain bound
to an unsynapsed end long enough to perform second
strand cleavage (Figure 5 bottom right). Such uncon-
strained cleavage is an inherent danger of the preformed
transposase dimer and is not peculiar to the mutants. Even
with the wild-type transposase, the tell tale linear product
accumulates after a long incubation under OPI conditions
(Supplementary Figure S7A, rightmost lane).
Because OPI is caused by saturation of the transposon
ends with transposase dimers, it can be overcome by faster
synapsis (13). This is because fewer windows of opportun-
ity, represented by the occasional dissociation of a
transposase dimer, are required to capture a naked end.
OPI can also be overcome by increasing the OFF-rate of
the transposase dimer for a similar reason (13). However,
the EMSA suggests that this is not the case for the
mutants, which release the free transposon end at about
the same rate as wild-type transposase (Figure 4D and
Supplementary Figure S10).
To understand how faster synapsis is achieved in the
mutants, it is important to recall that the ASO mechanism
is ampliﬁed by allosterism, which lowers the afﬁnity of the
single-end complex for the second transposon end. This
increases the competition for transposase binding sites by
orders of magnitude (13). Therefore, the mutants could
achieve fast synapsis if they increased the rate of the
conformational change that restores the afﬁnity of the
complex for the transposon end. This would be the same
conformational change that produces the pseudo-
activated state responsible for the unconstrained catalysis
in the mutants (Figure 5 blue and yellow to green
decagon). However, it is worth noting that the model is
a simpliﬁcation and that synapsis probably involves more
sub-steps than illustrated.
In the present work, we have focused on the interactions
between the clamp-loop and linker highlighted by the
crystal structure of the post-cleavage intermediate.
However, it seems likely that the extent and nature of
the subunit interface(s) change during the progression of
the reaction (e.g. Figure 5). Additional regions of the
protein may therefore harbor potentially hyperactive
mutations.
The most highly active variants of the PiggyBac and
Sleeping Beauty transposons were created by combining
several independently isolated hyperactive point muta-
tions (6,7). In both cases, the mutations are distributed
throughout the respective proteins. This may be owing
to the fact that the original isolates were suboptimal
variants generated by genetic drift. However, the dose-
response curves for the PiggyBac and Sleeping Beauty
transposases hint that these elements may, like Hsmar1,
be regulated by an ASO mechanism (13). The ASO mech-
anism could also ﬁt with a wide distribution of hyperactive
mutations because it depends on so many aspects of a
protein’s behavior. Under OPI conditions the degree of
inhibition is dictated by the ON- and OFF-rates for trans-
poson end binding, the stability of the protein, which
affects its steady-state concentration, and the subunit
interfaces that mediate allosterism or any of the conform-
ational changes as the reaction progresses.
Finally, it is worth noting that the wild-type transposase
has the potential for unconstrained catalysis. This may
help to explain the so-called self-inﬂected wounds
detected at Mos1 ends in Drosophila (30). It has been
suggested that the wounds might be an adaptive feature
of the reaction, representing a self-destructive form of
autoregulation. However, a more likely explanation may
be that Mos1 represents a suboptimal transposase variant,
which arose as a result of genetic drift. In contrast, the
tight coupling between catalysis and synapsis in Hsmar1 is
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probably an adaptive feature of the reaction, lowering the
genetic burden of the transposon on the host.
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